"Always Up for a Good Battle": CME Takes Aim at CFTC in High-Stakes Lawsuit Over Perps

Outgoing CME Group CEO Terrence Duffy revealed that the world's largest derivatives marketplace will file a federal lawsuit against the Commodity Futures Trading Commission (CFTC) over the agency's decision to greenlight crypto perpetual futures in the United States.

Talking to CMBC’s Fast Money, Duffy said that the lawsuit will directly target the CFTC's late-May authorisation of Kalshi's BTCPERP contract, the first regulated crypto perpetual futures product in US history, and a related no-action letter issued to Coinbase.

Duffy Pulls No Punches

Duffy, who is simultaneously stepping down as CME's top role, described the CFTC's approval process as rushed and legally flawed, arguing it bypassed a mandatory full review required for products the agency had classified as "novel and complex."

"Perpetuals are effectively swaps," he said, adding that CME holds exclusive benchmark licensing agreements that would require all such contracts to route through its infrastructure. On the prospect of fighting the very regulator that oversees his exchange, Duffy was characteristically blunt; he is, in his own words, “always up for a good battle.”

Perps vs. Swaps: The Distinction That Could Reshape US Crypto Markets

The crux of CME's legal argument is a technically loaded classification question. Traditional futures are standardised contracts to buy or sell an asset at a set price on a fixed expiry date: they settle, they close.

Perpetual futures have no expiry. Traders hold leveraged positions indefinitely, with a periodic funding rate exchanged between longs and shorts to keep the contract price tethered to spot.

You may also like: Perps vs CFDs and Futures - What Brokers Need to Know Before Adding Crypto’s Hottest Derivative

Duffy argues that an open-ended, rolling, cash-settled structure makes perps functionally identical to swaps; bilateral derivative contracts regulated under Dodd-Frank with mandatory clearing, dealer registration, and strict margin requirements. If a federal court agrees, U.S.-listed perps would face a far heavier compliance burden and, given CME's licensing claims, would arguably need to clear through CME's own systems, dealing a significant blow to Kalshi, Coinbase, and Kraken, which have only just entered the space.

Systemic Risk at the Core

Beyond the classification argument, Duffy has raised a broader macro alarm. Perps on crypto exchanges routinely offer leverage of 50-to-1 or higher, backed by automated liquidation mechanisms that force-close positions when margin thresholds are breached.

He earlier warned at the Piper Sandler Global Exchange & Fintech Conference that this mirrors the structural vulnerabilities that amplified losses in 2008: "This is a catastrophe in the making."

Read more: CySEC Chair on Crypto Perps, Prediction Markets and the High-Wire Act of EU Regulation

CFTC leadership appears to be pushing back firmly. The agency's position, as articulated publicly, is straightforward: It wants to regulate perps locally and seal the offshore gap.

If the court sides with CME, regulators could face pressure to roll back existing approvals and impose swap-level oversight on all perp products. If the CFTC prevails, it would signal broad judicial backing for the agency's authority to approve novel derivatives structures, potentially opening the door to a wider class of crypto products entering US markets.

Either way, Terrence Duffy's final act as CME Group CEO may prove to be one of his most consequential.